FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Examine Value Of Robo Advisor Performance Relative To Fees to see how fee structures influence long-term ROI and value.
23,313 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
A triple-leveraged note tied to a tech stock basket plunged 18% in a single session, erasing much of a year’s gains a...
In 2026, equal-weight XSD and cap-weight SMH offer contrasting bets on AI-driven chipmakers. This article analyzes ho...
Mattel announces a bold 2026 transformation to become an IP-driven entertainment platform, deploying $150 million for...
Fidelity’s Emerging Markets ETF has surged about 30% year-to-date, driven by chipmakers and Chinese tech names, yet r...
A pure bitcoin-miner fund surged, delivering gains far beyond a wide blockchain ETF as crypto markets rebounded. Here...
Two high-yield closed-end funds are sparking debate as one slashes distributions and the other maintains payments. He...
A smart way to jump into AI semiconductors starts with a modest, well-balanced plan. Here are three no-brainer AI sto...
Match Group’s HR chief outlines a policy-first approach to workplace romances, arguing transparency and clear disclos...
NVIDIA Just Surpassed Silver marks a seismic moment in asset valuation. This story breaks down what’s driving the sur...
Fairholme trimmed its stake in The St. Joe Company, but that doesn’t mean the stock isn’t worth a closer look. Here’s...
As software shares pull back in 2026, you don’t have to chase chaos. This article identifies one software stock actua...